UK Auto-injectors Market Size & Outlook, 2026-2033
Related Markets
UK auto-injectors market highlights
- The UK auto-injectors market generated a revenue of USD 465.9 million in 2025 and is expected to reach USD 1,308.1 million by 2033.
- The UK market is expected to grow at a CAGR of 13.9% from 2026 to 2033.
- In terms of segment, diabetes was the largest revenue generating disease indication in 2025.
- Multiple Sclerosis is the most lucrative disease indication segment registering the fastest growth during the forecast period.
Auto-injectors market data book summary
| Market revenue in 2025 | USD 465.9 million |
| Market revenue in 2033 | USD 1,308.1 million |
| Growth rate | 13.9% (CAGR from 2026 to 2033) |
| Largest segment | Diabetes |
| Fastest growing segment | Multiple Sclerosis |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anaphylaxis, Diabetes, Rheumatoid Arthritis, Other Therapies, Multiple Sclerosis |
| Key market players worldwide | Eli Lilly and Co, SHL Medical, AbbVie Inc, Amgen Inc, Owen Mumford, Ypsomed Holding AG, Teva Pharmaceutical Industries Ltd, Biogen Inc, Mylan, Pfizer Inc, Sanofi SA, Gerresheimer AG ADR |
Other key industry trends
- In terms of revenue, UK accounted for 4.6% of the global auto-injectors market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany auto-injectors market is projected to lead the regional market in terms of revenue in 2033.
- Norway is the fastest growing regional market in Europe and is projected to reach USD 481.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Auto-Injectors Market Scope
Auto-Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| SHL Medical | View profile | 1001-5000 | Zug, Zug, Switzerland, Europe | https://www.shl-medical.com/ |
| Owen Mumford | View profile | 501-1000 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.owenmumford.com/en/ |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Gerresheimer AG ADR | View profile | 11660 | Klaus-Bungert-Strasse 4, Duesseldorf, NW, Germany, 40468 | https://www.gerresheimer.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
UK auto-injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to auto-injectors market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 32.13% in 2025. Horizon Databook has segmented the UK auto-injectors market based on anaphylaxis, diabetes, rheumatoid arthritis, other therapies, multiple sclerosis covering the revenue growth of each sub-segment from 2021 to 2033.
In the UK, the auto-injectors market is growing due to the rising prevalence of allergies, with over 20% of the UK population suffering from at least one allergy, making adrenaline autoinjectors (AAIs) vital for those at risk of anaphylaxis, capable of saving lives, according to Medicines and Healthcare products Regulatory Agency data published in June 2023.
AAIs like Epipens and Jext are prescribed for these individuals. NHS Digital’s Hospital Episode Statistics reveal that allergy and anaphylaxis hospital admissions in England have almost doubled over twenty years, from 13,440 in 2001-02 to over 26,000 in 2021-22, thereby fueling the market expansion.
Reasons to subscribe to UK auto-injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK auto-injectors market databook
-
Our clientele includes a mix of auto-injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK auto-injectors market, including forecasts for subscribers. This country databook contains high-level insights into UK auto-injectors market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
UK auto-injectors market size, by disease indication, 2021-2033 (US$M)
UK Auto-Injectors Market Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
